Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Bicycle Therapeutics (BCYC) Income from Continuing Operations: 2018-2025

Historic Income from Continuing Operations for Bicycle Therapeutics (BCYC) over the last 8 years, with Sep 2025 value amounting to -$59.1 million.

  • Bicycle Therapeutics' Income from Continuing Operations fell 16.33% to -$59.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$256.4 million, marking a year-over-year decrease of 53.84%. This contributed to the annual value of -$174.8 million for FY2024, which is 3.49% up from last year.
  • According to the latest figures from Q3 2025, Bicycle Therapeutics' Income from Continuing Operations is -$59.1 million, which was up 25.14% from -$79.0 million recorded in Q2 2025.
  • Bicycle Therapeutics' Income from Continuing Operations' 5-year high stood at -$14.7 million during Q3 2021, with a 5-year trough of -$79.0 million in Q2 2025.
  • Over the past 3 years, Bicycle Therapeutics' median Income from Continuing Operations value was -$49.9 million (recorded in 2023), while the average stood at -$50.4 million.
  • Per our database at Business Quant, Bicycle Therapeutics' Income from Continuing Operations soared by 32.13% in 2024 and then tumbled by 129.10% in 2025.
  • Quarterly analysis of 5 years shows Bicycle Therapeutics' Income from Continuing Operations stood at -$19.1 million in 2021, then tumbled by 94.02% to -$37.0 million in 2022, then crashed by 34.01% to -$49.6 million in 2023, then decreased by 16.31% to -$57.6 million in 2024, then decreased by 16.33% to -$59.1 million in 2025.
  • Its Income from Continuing Operations stands at -$59.1 million for Q3 2025, versus -$79.0 million for Q2 2025 and -$60.7 million for Q1 2025.